Inventor

Fukang Yang

Inventor
Madison, CT, US

Overview

27→
Patents
2010–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
H01LSemiconductor devices2%
H10DInorganic electric semiconductor devices2%
H10PGeneric processes or apparatus for the manufacture or treatment of devices covered by class h102%
H10WGeneric packages, interconnections, connectors or other constructional details of devices covered by class h102%
B64CAeroplanes1%
B64UUnmanned aerial vehicles [uav]1%
PatentTitleYear
11,107,902Dielectric spacer to prevent contacting shorting202111,073,841Methods and systems for launching an unmanned aerial vehicle202111,062,945Methods for reducing contact depth variation in semiconductor fabrication202110,287,291Seco-cyclopropapyrroloindole compounds, antibody-drug conjugates thereof, and methods of making and use20199,758,487'Hepatitis C virus inhibitors'20179,688,669'Oxazolidinones as modulators of mGluR5'20179,227,961'Hepatitis C virus inhibitors'20169,018,390'Hepatitis C virus inhibitors'20158,846,023'Hepatitis C virus inhibitors'20148,735,398'Hepatitis C virus inhibitors'20148,691,821'Oxazolidinones as modulators of mGluR5'20148,642,025'Hepatitis C virus inhibitors'20148,629,171'Crystalline form of methyl ((1S)-1-((25)-2-(5-(4\'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt'20148,574,563'Hepatitis C virus inhibitors'20138,492,553'Hepatitis C virus inhibitors'20138,362,020'Hepatitis C virus inhibitors'20138,303,944'Hepatitis C virus inhibitors'20128,288,562'Hepatitis C virus inhibitors'20128,147,818'Hepatitis C virus inhibitors'20128,143,288'Inhibitors of HCV replication'20128,093,243'Hepatitis C virus inhibitors'20127,906,655'Hepatitis C virus inhibitors'20117,759,495'Hepatitis C virus inhibitors'20107,745,636'Hepatitis C virus inhibitors'20107,741,347'Hepatitis C virus inhibitors'20107,704,992'Hepatitis C virus inhibitors'20107,659,270'Hepatitis C virus inhibitors'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2019Patents assigned to BRISTOL MYERS SQUIBB CO (24)· patent assignee history
2010–2019Based in Madison, CT, US· patent location history
2012–2014Patents assigned to YANG FUKANG (10)· patent assignee history
2012–2014Patents assigned to SNYDER LAWRENCE B (9)· patent assignee history
2012–2013Patents assigned to ST LAURENT DENIS R (8)· patent assignee history
2012–2013Patents assigned to BELEMA MAKONEN (7)· patent assignee history
2021Based in Hsinchu, TW· patent location history
2021Based in Tainan, TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO242010–2019
YANG FUKANGself102012–2014
SNYDER LAWRENCE B92012–2014
ST LAURENT DENIS R82012–2013
BELEMA MAKONEN72012–2013
Locations
LocationPatentsSpan
Madison, CT, US242010–2019
Hsinchu, TW22021
Tainan, TW12021